Allylescaline: Difference between revisions
Jump to navigation
Jump to search
m Protected "Allylescaline": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
| Line 21: | Line 21: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
== See also == | == See also == | ||
Latest revision as of 14:16, 4 September 2012
| AL | |
|---|---|
| Chemical name | 4-allyloxy-3,5-dimethoxyphenethylamine or 4-allyloxy-3,5-dimethoxy-1-ethylamine |
| Chemical formula | C13H19NO3 |
| Molecular mass | 237.29 g/mol |
| SMILES | COc1cc(cc(OC)c1OCC=C)CCN |
| File:AL-PEA.png File:Allylescaline-3d-sticks.png | |
Allylescaline, or 4-allyloxy-3,5-dimethoxyphenethylamine, is a lesser-known psychedelic drug. It is closely related in structure to Mescaline. AL was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved), the dosage range is listed as 20-35 mg, and the duration 8-12 hours.[1] AL produces an entactogenic warmth, an entheogenic effect, and a feeling of flowing energy. Very little data exists about the pharmacological properties, metabolism, and toxicity of AL.